DCF — CARILION MEDICAL CENTER
Enterprise Value: $-2.6B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.6B
Enterprise Value
$-808.9M
PV of Cash Flows
$-1.8B
PV of Terminal Value
$-2.8B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.5B | $-161.9M | -11.0% | $-225.5M | $-205.0M |
| Year 2 | $1.5B | $-151.2M | -10.0% | $-216.8M | $-179.2M |
| Year 3 | $1.6B | $-139.8M | -9.0% | $-207.3M | $-155.8M |
| Year 4 | $1.6B | $-135.8M | -8.0% | $-205.4M | $-140.3M |
| Year 5 | $1.7B | $-135.7M | -8.0% | $-207.3M | $-128.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.6B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.5B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11266687998665412
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5